Treatment variations in cerebral venous thrombosis: An international survey

Cerebrovascular Diseases

Volumn 32, Issue 3, 2011, Pages 298-300

  Coutinho, J M ^a   Seelig, R ^a   Bousser, M G ^b   Canhao P ^c   Ferro, J M ^c   Stam, J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICONVULSIVE AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; CRANIECTOMY; EPILEPSY; HEALTH SURVEY; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; TREATMENT DURATION;

ANTICOAGULANTS; ANTICONVULSANTS; ASIA; DECOMPRESSIVE CRANIECTOMY; EUROPE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INTRACRANIAL THROMBOSIS; NORTH AMERICA; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SOUTH AMERICA; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 80052597053     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000330646     Document Type: Review

References (9)

1. Coutinho J, de Bruijn SF, Deveber G, Stam J: Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev 2011;8: CD002005.
2. Einhaupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, Masuhr F: EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17: 1229-1235.
3. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F: Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670. (Pubitemid 38280838)
4. Canhao P, Falcao F, Ferro JM: Thrombolytics for cerebral sinus thrombosis: A systematic review. Cerebrovasc Dis 2003; 15: 159-166. (Pubitemid 36351200)
5. Masuhr F, Busch M, Amberger N, Ortwein H, Weih M, Neumann K, Einhäupl K, Mehraein S: Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 2006; 13: 852-856. (Pubitemid 44124681)
6. Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F: Early seizures in cerebral vein and dural sinus thrombosis: Risk factors and role of antiepileptics. Stroke 2008; 39: 1152-1158. (Pubitemid 351440684)
7. Ferro JM, Lopes GC, Rosas MJ, Marques JM, Costafor JB: Do randomised clinical trials influence practice? The example of cerebral vein and dural sinus thrombosis. J Neurol 2002; 249: 1595-1596. (Pubitemid 35477904)
8. Hull RD, Pineo GF: Heparin and low-molecular-weight heparin therapy for venous thromboembolism: Will unfractionated heparin survive? Semin Thromb Hemost 2004; 30(suppl 1):11-23.
9. Ferro JM, Bousser MG, Barinagarrementeria F, Stam J, Canhao P: Variation in management of acute cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2002; 13(suppl 3):60.